93 related articles for article (PubMed ID: 19940522)
1. Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies.
Fiebiger W; Kaserer K; Rodler S; Oberbauer R; Bauer C; Raderer M
Oncology; 2009; 77(5):314-7. PubMed ID: 19940522
[TBL] [Abstract][Full Text] [Related]
2. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
3. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases.
Kanitakis J; Alhaj-Ibrahim L; Euvrard S; Claudy A
Arch Dermatol; 2003 Sep; 139(9):1133-7. PubMed ID: 12975154
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France.
Farge D
Eur J Med; 1993; 2(6):339-43. PubMed ID: 8252179
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
7. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
[TBL] [Abstract][Full Text] [Related]
9. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
10. Malignancies of the colorectum and anus in solid organ recipients.
Aigner F; Boeckle E; Albright J; Kilo J; Boesmueller C; Conrad F; Wiesmayr S; Antretter H; Margreiter R; Mark W; Bonatti H
Transpl Int; 2007 Jun; 20(6):497-504. PubMed ID: 17343685
[TBL] [Abstract][Full Text] [Related]
11. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
[TBL] [Abstract][Full Text] [Related]
12. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
13. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population.
Buell JF; Papaconstantinou HT; Skalow B; Hanaway MJ; Alloway RR; Woodle ES
Transplant Proc; 2005 Mar; 37(2):960-1. PubMed ID: 15848590
[TBL] [Abstract][Full Text] [Related]
14. Low recurrence of preexisting extrahepatic malignancies after liver transplantation.
Benten D; Sterneck M; Panse J; Rogiers X; Lohse AW
Liver Transpl; 2008 Jun; 14(6):789-98. PubMed ID: 18412260
[TBL] [Abstract][Full Text] [Related]
15. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience.
Veness MJ; Quinn DI; Ong CS; Keogh AM; Macdonald PS; Cooper SG; Morgan GW
Cancer; 1999 Apr; 85(8):1758-64. PubMed ID: 10223570
[TBL] [Abstract][Full Text] [Related]
16. [Melanoma in organ transplant patients].
Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
[TBL] [Abstract][Full Text] [Related]
17. Solid tumors after heart transplantation: lethality of lung cancer.
Pham SM; Kormos RL; Landreneau RJ; Kawai A; Gonzalez-Cancel I; Hardesty RL; Hattler BG; Griffith BP
Ann Thorac Surg; 1995 Dec; 60(6):1623-6. PubMed ID: 8787454
[TBL] [Abstract][Full Text] [Related]
18. Melanomas in renal transplant recipients.
Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
[TBL] [Abstract][Full Text] [Related]
19. Cardiac operations in solid-organ transplant recipients.
Mitruka SN; Griffith BP; Kormos RL; Hattler BG; Pigula FA; Shapiro R; Fung JJ; Pham SM
Ann Thorac Surg; 1997 Nov; 64(5):1270-8. PubMed ID: 9386690
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of BK virus replication among recipients of solid organ transplants.
Muñoz P; Fogeda M; Bouza E; Verde E; Palomo J; Bañares R;
Clin Infect Dis; 2005 Dec; 41(12):1720-5. PubMed ID: 16288394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]